Bharat Parenterals Limited (BOM:541096)
India
· Delayed Price · Currency is INR 1,139.95
+39.95 (3.63%)
At close: Jun 27, 2025
Bharat Parenterals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 3,404 | 2,574 | 2,180 | 2,120 | 2,046 | Upgrade
|
Other Revenue | - | 20.48 | 13.22 | 3.17 | 25.8 | Upgrade
|
| 3,404 | 2,594 | 2,193 | 2,123 | 2,072 | Upgrade
| |
Revenue Growth (YoY) | 31.21% | 18.29% | 3.28% | 2.46% | -10.99% | Upgrade
|
Cost of Revenue | 1,855 | 1,605 | 1,394 | 1,379 | 1,358 | Upgrade
|
Gross Profit | 1,549 | 989.47 | 799.43 | 744.1 | 714.06 | Upgrade
|
Selling, General & Admin | 496.6 | 245.37 | 187.63 | 159.33 | 153.81 | Upgrade
|
Other Operating Expenses | 1,025 | 478.36 | 354.64 | 273.18 | 285.1 | Upgrade
|
Operating Expenses | 1,875 | 813.93 | 601.1 | 499.11 | 499.2 | Upgrade
|
Operating Income | -326.2 | 175.54 | 198.33 | 244.99 | 214.86 | Upgrade
|
Interest Expense | -129.5 | -32.25 | -21.86 | -9.67 | -3.94 | Upgrade
|
Interest & Investment Income | - | 4.2 | 3.38 | 16.76 | 3.55 | Upgrade
|
Currency Exchange Gain (Loss) | - | 33.3 | 46.99 | 13.89 | 6.09 | Upgrade
|
Other Non Operating Income (Expenses) | 116.1 | 7.27 | 6.12 | 13.87 | 45.48 | Upgrade
|
EBT Excluding Unusual Items | -339.6 | 188.06 | 232.96 | 279.84 | 266.04 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 3.43 | 11.25 | 5.13 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -0.85 | -0.91 | -7.4 | 0.09 | Upgrade
|
Pretax Income | -339.6 | 187.22 | 235.47 | 283.69 | 271.25 | Upgrade
|
Income Tax Expense | 97.2 | 82.07 | 78.32 | 70.65 | 68.08 | Upgrade
|
Earnings From Continuing Operations | -436.8 | 105.14 | 157.15 | 213.04 | 203.16 | Upgrade
|
Minority Interest in Earnings | 310.5 | 40.03 | - | - | 0.73 | Upgrade
|
Net Income | -126.3 | 145.17 | 157.15 | 213.04 | 203.89 | Upgrade
|
Net Income to Common | -126.3 | 145.17 | 157.15 | 213.04 | 203.89 | Upgrade
|
Net Income Growth | - | -7.62% | -26.24% | 4.49% | -15.55% | Upgrade
|
Shares Outstanding (Basic) | - | 6 | 6 | 6 | 6 | Upgrade
|
Shares Outstanding (Diluted) | - | 6 | 6 | 6 | 6 | Upgrade
|
Shares Change (YoY) | - | 0.81% | 0.60% | 0.19% | - | Upgrade
|
EPS (Basic) | - | 24.94 | 27.21 | 37.11 | 35.59 | Upgrade
|
EPS (Diluted) | - | 24.94 | 27.21 | 37.11 | 35.59 | Upgrade
|
EPS Growth | - | -8.37% | -26.67% | 4.29% | -15.55% | Upgrade
|
Free Cash Flow | -563.3 | -1,090 | -699.37 | -268.38 | 236.07 | Upgrade
|
Free Cash Flow Per Share | - | -187.25 | -121.11 | -46.75 | 41.20 | Upgrade
|
Dividend Per Share | 1.000 | 1.000 | 0.750 | - | - | Upgrade
|
Dividend Growth | - | 33.33% | - | - | - | Upgrade
|
Gross Margin | 45.51% | 38.14% | 36.45% | 35.04% | 34.46% | Upgrade
|
Operating Margin | -9.58% | 6.77% | 9.04% | 11.54% | 10.37% | Upgrade
|
Profit Margin | -3.71% | 5.60% | 7.17% | 10.03% | 9.84% | Upgrade
|
Free Cash Flow Margin | -16.55% | -42.02% | -31.89% | -12.64% | 11.39% | Upgrade
|
EBITDA | 27 | 265.74 | 257.15 | 311.6 | 275.15 | Upgrade
|
EBITDA Margin | 0.79% | 10.24% | 11.73% | 14.67% | 13.28% | Upgrade
|
D&A For EBITDA | 353.2 | 90.21 | 58.82 | 66.61 | 60.29 | Upgrade
|
EBIT | -326.2 | 175.54 | 198.33 | 244.99 | 214.86 | Upgrade
|
EBIT Margin | -9.58% | 6.77% | 9.04% | 11.54% | 10.37% | Upgrade
|
Effective Tax Rate | - | 43.84% | 33.26% | 24.90% | 25.10% | Upgrade
|
Revenue as Reported | 3,520 | 2,660 | 2,297 | 2,198 | 2,133 | Upgrade
|
Advertising Expenses | - | 17.55 | 7.67 | 6.23 | 5.51 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.